Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 44.69B | 45.52B | 45.86B | 40.97B | 51.12B | 53.49B |
Gross Profit | 9.59B | 9.24B | 9.14B | 7.49B | 9.31B | 10.13B |
EBITDA | 1.67B | 1.45B | 1.22B | 21.88M | 784.93M | 1.14B |
Net Income | 1.15B | 673.08M | 648.47M | -245.66M | 326.31M | 509.31M |
Balance Sheet | ||||||
Total Assets | 51.94B | 50.55B | 46.41B | 49.91B | 46.89B | 52.61B |
Cash, Cash Equivalents and Short-Term Investments | 7.33B | 10.43B | 11.64B | 13.25B | 9.04B | 8.96B |
Total Debt | 26.27B | 18.41B | 16.90B | 21.74B | 19.67B | 23.40B |
Total Liabilities | 37.41B | 35.23B | 31.50B | 35.40B | 31.84B | 35.69B |
Stockholders Equity | 14.53B | 15.32B | 14.91B | 14.52B | 15.05B | 16.92B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | -2.46B | 3.52B | 2.45B | 4.14B | 5.90B |
Operating Cash Flow | 0.00 | -2.37B | 3.54B | 2.56B | 4.18B | 6.11B |
Investing Cash Flow | 0.00 | -46.47M | -16.50M | -117.80M | 462.77M | -106.08M |
Financing Cash Flow | 0.00 | 1.21B | -5.13B | 1.78B | -3.99B | -5.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥5.80B | 6.95 | 4.27% | -4.39% | 1969.50% | ||
65 Neutral | ¥7.59B | 11.39 | 3.64% | -0.75% | 2.98% | ||
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% | |
59 Neutral | ¥11.36B | 48.20 | 4.76% | 0.38% | -73.76% | ||
57 Neutral | ¥10.19B | 7.88 | 733.24% | 47.96% | -2.86% | ||
56 Neutral | ¥5.05B | ― | 1.85% | -21.44% | 34.07% |